Inflammation of the mammary gland most commonly caused by bacterial colonization within the gland; other causes may include neoplasia and mycotic infection.
Initial infection may occur by hematogenous spread, adjacent dermatologic inflammation, or, most commonly, ascending infection via the teat canal. Bacterial colonization of the teat cistern does not always lead to mastitis, which suggests failure of the immune system locally or systemically. Inflammation may involve 1 or several lobes of 1 or both mammary glands. Cellular debris clogs the teat canal and leads to an increase in pressure within the gland, no effective drainage, and the infection may spread to surrounding tissues.
Incidence is low. Protective factorsfrequent nursing by the foal, a short lactation period, and small teats.
Reluctance of the mare to allow the foal to nurse, depression, anorexia, and severe adverse behavior when udder is palpated.
Leukocytosis with neutrophilia, hyperfibrinogenemia, increased SAA, or anemia of chronic disease possible.
Samples from each teat cistern should be collected aseptically and submitted for aerobic culture and cytologic examination for definitive diagnosis. Gram-stain preparations of mammary secretions or milk may guide initial treatment. Anaerobes are not significant bacterial pathogens. Cytologic examination of milkoften acellular or contains rare neutrophils from normal, lactating mares; contains macrophages with vacuoles present (foam cells) and lymphocytes in the drying-off period; shows numerous intact and degenerated neutrophils and cellular debris, and may show large numbers of bacteria or fungal hyphae with mastitis. Mammary gland biopsy indicated if clinical signs are not responsive to initial treatment for bacterial infection, or if cytologic examination is not suggestive of infectious mastitis.
Palpate udder and take rectal temperature daily. Treatment should continue for a minimum of 57 days or until 24 h after signs have resolved. If abnormalities in the peripheral blood exist, repeat CBC, fibrinogen, or SAA. Renal function should be monitored with long-term aminoglycoside and nonsteroidal administration.